Kato Medical, a medical technology company developing advanced surgical navigation and guidance systems, has secured strategic investment from Kyocera Ventures and ReefHaven Ventures to accelerate the development and commercialization of its next-generation surgical technology. The investment will support the company’s continued growth as it advances toward regulatory milestones, including its planned FDA submission, and expands its work in artificial intelligence, 3D tracking, and precision surgical guidance.

Founded to improve surgical outcomes, safety, and efficiency, Kato Medical is developing technology that combines artificial intelligence, neural networks, and machine perception to provide surgeons with enhanced navigation capabilities during procedures. The company’s platform is designed to improve precision in orthopedic surgery and guided needle procedures by integrating advanced imaging and real-time spatial tracking.

Kyocera Ventures made a strategic investment in Kato Medical as part of its focus on supporting early-stage companies developing transformative technologies. Kyocera Ventures is the venture capital arm of Kyocera Corporation, a global technology company with expertise in advanced materials, manufacturing, and engineering. The firm invests in startups from seed through Series B stages and supports companies working on innovative solutions across healthcare, technology, and industrial sectors.

ReefHaven Ventures also invested in Kato Medical. The early-stage venture fund focuses on healthcare founders developing medical technologies and works with entrepreneurs building solutions designed to move innovations from research and development into clinical applications. The investment reflects growing interest in medical technology companies using artificial intelligence and advanced engineering to improve patient care.

Kato Medical’s flagship technology, FASTRACK, is designed to provide surgical navigation capabilities through a combination of AI-powered image processing, 3D tracking, and machine perception. The system uses a proprietary neural network architecture to combine preoperative CT scans with intraoperative fluoroscopy, allowing surgeons to achieve high levels of precision without relying on costly and time-consuming intraoperative CT systems.

The company’s technology aims to address challenges in modern surgery, where surgeons require increasingly accurate tools to perform complex procedures safely and efficiently. By providing real-time spatial navigation and improved visualization, Kato Medical seeks to help surgeons make more informed decisions during operations while reducing procedural complexity.

The strategic investment comes after Kato Medical completed its design phase and began preparing for regulatory submission. Founder and CEO Albert Hill said the investment would accelerate the company’s path toward FDA submission, which was targeted for the first quarter of 2026. The company has been working with surgeons and industry experts through validation activities and design labs to refine its technology and ensure it addresses real-world clinical needs.

Kato Medical’s platform is built around the idea of surgeon-collaborative technology, where artificial intelligence supports medical professionals rather than replacing their expertise. The company is developing systems designed to enhance perception, control, and tactile awareness during procedures, potentially enabling more precise and consistent surgical outcomes.

The investment from Kyocera Ventures and ReefHaven Ventures provides Kato Medical with additional resources to advance engineering, regulatory preparation, and commercialization efforts. Strategic backing from investors with expertise in technology and healthcare is expected to help the company move closer to bringing its surgical navigation solutions into clinical environments.

The medical technology sector has seen increasing adoption of artificial intelligence and advanced imaging technologies as healthcare providers seek ways to improve efficiency, reduce risks, and enhance patient outcomes. Surgical navigation systems are becoming an important area of innovation, particularly in specialties such as orthopedics, where precision can have a significant impact on recovery and long-term results.

Kato Medical is positioning itself within this expanding market by developing a platform that integrates multiple emerging technologies into a single surgical guidance system. The company’s combination of AI, neural networks, and 3D tracking is designed to provide surgeons with a more comprehensive understanding of patient anatomy and procedural requirements.

With new strategic investment from Kyocera Ventures and ReefHaven Ventures, Kato Medical plans to continue advancing its surgical technology platform, complete regulatory steps, and prepare for future commercialization. The company aims to improve surgical precision and help healthcare providers deliver safer, more efficient procedures through AI-enabled medical innovation.

Related Articles